Endocrine, Metabolic & Immune Disorders Drug Targets , vol
Scientific Communications: SVD and cogniton 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.01 - PREVENTION O - ESOC25-2242 INVESTIGATING THE ASSOCIATION OF A BRAIN CARE SCORE WITH STRUCTURAL BRAIN CHANGES AND COGNITIVE IMPAIRMENT Jenna Schellin 1 , Susanne Sehner 1 , Marie Neumann 1 , Marvin Petersen 1 , Felix Ngele 1 , Sanjula Singh 2,3,4,5 , Jonathan Rosand 2,3,4,5 , Nils Schumacher 6 , Birgit-Christiane Zyriax 1 , Raphael Twerenbold 1 , Bastian Cheng 1 , Gtz Thomalla, Mrit Jensen 1 1 University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 2 Broad Institute of MIT and Harvard, Cambridge, MA, United States, Boston, United States, 3 Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, United States, 4 Center for Genomic Medicine, Massachusetts General Hospital, Boston, United States, 5 Department of Neurology, Massachusetts General Hospital, Boston, United States, 6 Faculty of Psychology and Human Movement, Institute of Human Movement Science, University of Hamburg, Hamburg, Germany Background and Aims: The Brain Care Score (BCS) aims to encourage patients to change their behavior in order to modify risk factors and prevent dementia
POSTED BY TORONTO FUNCTIONAL MEDICINE CENTRE Methylation sounds like a word used in a lab, but its something we should understand for optimal health
Die meisten rekombinanten Proteine werden als Fusionen mit kurzen Affinittstags oder kleine Proteine wie beispielsweise Glutathion-S-Transferase (GST) exprimiert
